Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,796.00
(
0.00%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
109.64
(
2.87%
)
Bitcoin
69,869.76
(
-1.93%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

poorgradstudent

Send PM Follow Ignore
Followers 71
Posts 3426
Boards Moderated 1
Alias Born 04/28/2004

poorgradstudent

Re: gfp927z post# 88489

Monday, 01/04/2010 9:55:34 PM

Monday, January 04, 2010 9:55:34 PM

Post# of 257257
APPA:

>if you conservatively project peak annual sales of APF-530 ramping up to $100-150 mil range (Aloxi currently over $400 mil annually)<

If I understand correctly, the trial was for non-inferiority.

If so, why would you expect it to be able to take ~30% of Aloxi's market? What is the selling point?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now